Labcorp Holdings Inc. closed 9.72% below its 52-week high of $258.59, which the company reached on March 5th.
Redburn Atlantic initiated coverage of Labcorp (LH) with a Buy rating and $276 price target Don't Miss Our End of Quarter Offers: Discover the ...
Labcorp (LH) will offer nationwide an FDA-approved human papillomavirus self-collection solution that can help women and their physicians asses ...
A New Jersey laboratory which had parts of its business acquired by Labcorp earlier this month has laid off 81 employees. BioReference Health terminated the employees from its headquarters in ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The stock's rise snapped a four-day losing streak.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results